Search research articles
Contact Us
Filters
Showing results (41-50 of 120) with videos related to
Page
of 12
Sort By:
The Lancet. Oncology
|
February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study
Caineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Cancer
|
June 8, 2019
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer
Eric J Sherman, Lara A Dunn, Heiko Schöder, et al.
Oral Oncology
|
May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
Antoine Desilets, David G Pfister, Sarah Stein, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 26, 2024
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
Bin Xu, Marina K Baine, Achim Jungbluth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 11, 2011
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review
Eric J Sherman, Su Hsien Lim, Alan L Ho, et al.
Histopathology
|
December 4, 2024
Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions
Ying-Hsia Chu, Nora Katabi, Purvil Sukhadia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2024
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma
Christopher A Barker, Suzanne Dufault, Sarah T Arron, et al.
Cancer
|
June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer
Eric J Sherman, Lara A Dunn, Alan L Ho, et al.
The Journal of Experimental Medicine
|
April 24, 2025
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression
Chun-Hao Chen, Boris Reva, Nora Katabi, et al.
Cancer Research
|
May 16, 2018
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers
Brian R Untch, Vanessa Dos Anjos, Maria E R Garcia-Rendueles, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 120) with videos related to
Sort By:
Page
of 12
The Lancet. Oncology
|
February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study
Caineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Cancer
|
June 8, 2019
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer
Eric J Sherman, Lara A Dunn, Heiko Schöder, et al.
Oral Oncology
|
May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
Antoine Desilets, David G Pfister, Sarah Stein, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 26, 2024
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
Bin Xu, Marina K Baine, Achim Jungbluth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 11, 2011
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review
Eric J Sherman, Su Hsien Lim, Alan L Ho, et al.
Histopathology
|
December 4, 2024
Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions
Ying-Hsia Chu, Nora Katabi, Purvil Sukhadia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2024
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma
Christopher A Barker, Suzanne Dufault, Sarah T Arron, et al.
Cancer
|
June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer
Eric J Sherman, Lara A Dunn, Alan L Ho, et al.
The Journal of Experimental Medicine
|
April 24, 2025
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression
Chun-Hao Chen, Boris Reva, Nora Katabi, et al.
Cancer Research
|
May 16, 2018
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers
Brian R Untch, Vanessa Dos Anjos, Maria E R Garcia-Rendueles, et al.
Page
of 12